PedAM
Pediatric Disease Annotations & Medicines
| Disease | rheumatoid arthritis |
| Symptom | |vascular disease |
| Sentences | 67 |
| PubMedID- 21073447 | Lack of association between adipoq rs266729 and adipoq rs1501299 polymorphisms and cardiovascular disease in rheumatoid arthritis patients. |
| PubMedID- 22272574 | Influence of mhciita rs3087456 and rs4774 polymorphisms in the susceptibility to cardiovascular disease of patients with rheumatoid arthritis. |
| PubMedID- 23079082 | Introduction: recent studies revealed that co-morbidity and mortality due to cardiovascular disease are increased in patients with rheumatoid arthritis (ra) but little is known about factors involved in these manifestations. |
| PubMedID- 22161801 | Results of prior studies have suggested that methotrexate (mtx) may improve vascular disease in patients with psoriasis and rheumatoid arthritis. |
| PubMedID- 21420089 | Tnfa -308 (rs1800629) polymorphism is associated with a higher risk of cardiovascular disease in patients with rheumatoid arthritis. |
| PubMedID- 20827876 | Cardiovascular disease in rheumatoid arthritis: disease and treatment interactions and their implications on treatment decisions. |
| PubMedID- 22337612 | Apolipoprotein b-containing lipoprotein subclasses as risk factors for cardiovascular disease in patients with rheumatoid arthritis. |
| PubMedID- 21846359 | Ccr5delta32 variant and cardiovascular disease in patients with rheumatoid arthritis: a cohort study. |
| PubMedID- 23848174 | Cardiovascular diseases in patients with rheumatoid arthritis: comment on the article by koivuniemi et al. |
| PubMedID- 20040642 | Risk factors for cardiovascular disease in rheumatoid arthritis: defining treatment thresholds. |
| PubMedID- 23204310 | Atherosclerosis and cardiovascular disease in rheumatoid arthritis. |
| PubMedID- 23899926 | Angiopoietin-2 serum levels correlate with severity, early onset and cardiovascular disease in patients with rheumatoid arthritis. |
| PubMedID- 25026799 | Cardiovascular diseases in patients with rheumatoid arthritis during long-term methotrexate therapy. |
| PubMedID- 23749610 | Non-steroidal anti-inflammatory drugs and risk of cardiovascular disease in patients with rheumatoid arthritis: a nationwide cohort study. |
| PubMedID- 21276397 | Excess mortality from cardiovascular disease in patients with rheumatoid arthritis. |
| PubMedID- 23244227 | Cardiovascular diseases in patients with rheumatoid arthritis. |
| PubMedID- 22513132 | The excess risk of cardiovascular disease (cvd) associated with rheumatoid arthritis (ra) has long been recognized . |
| PubMedID- 21385539 | Lack of association between lep rs2167270 (19 g>a) polymorphism and disease susceptibility and cardiovascular disease in patients with rheumatoid arthritis. |
| PubMedID- 20735865 | Palomino-morales and colleagues 1 report the novel observation that a common polymorphism in the gene for methylene tetrahydrofolate reductase (mthfr) that markedly reduces enzyme activity (by as much as 65% in homozygotes) may predispose to the development of atherosclerotic cardiovascular disease (ascvd) in patients with rheumatoid arthritis (ra). |
| PubMedID- 20868308 | Objectives: rheumatoid arthritis (ra) is associated with cardiovascular disease (cvd). |
| PubMedID- 25969671 | Several epidemiological studies reported increased morbidity and mortality from cardiovascular diseases in patients with rheumatoid arthritis . |
| PubMedID- 24585741 | Objective: despite numerous studies reporting increased cardiovascular disease (cvd) in patients with rheumatoid arthritis (ra), the impact of ra on managing modifiable cvd risk factors remains understudied. |
| PubMedID- 26362702 | Risk factors for cardiovascular disease in rheumatoid arthritis patients from mato grosso do sul. |
| PubMedID- 21180241 | Platelet histogram indices and cardiovascular disease in patients with rheumatoid arthritis. |
| PubMedID- 22657383 | Association of the methionine sulfoxide reductase a rs10903323 gene polymorphism with cardiovascular disease in patients with rheumatoid arthritis. |
| PubMedID- 20638217 | Objective: this paper describes the rationale and design of a theory-informed patient education programme addressing cardiovascular disease for people with rheumatoid arthritis (ra) to illustrate how theory can explicitly be translated into practice. |
| PubMedID- 26117596 | Prevention of cardiovascular disease in rheumatoid arthritis. |
| PubMedID- 22360682 | Lack of association between tlr4 rs4986790 polymorphism and risk of cardiovascular disease in patients with rheumatoid arthritis. |
| PubMedID- 24795506 | Lack of association between abo, ppap2b, adamst7, pik3cg, and ednra and carotid intima-media thickness, carotid plaques, and cardiovascular disease in patients with rheumatoid arthritis. |
| PubMedID- 20383550 | Atherosclerosis plays a key role in cardiovascular disease in patients with rheumatoid arthritis (ra). |
| PubMedID- 24498997 | Single-nucleotide polymorphisms at the 9p21.3 genomic region not associated with the risk of cardiovascular disease in patients with rheumatoid arthritis. |
| PubMedID- 21269581 | Analysis of the influence of the ghrelin receptor rs509035, rs512692 and rs2922126 polymorphisms in the risk of cardiovascular disease in patients with rheumatoid arthritis. |
| PubMedID- 22337246 | Hypothyroidism as a risk factor for development of cardiovascular disease in patients with rheumatoid arthritis. |
| PubMedID- 21411091 | Prediction of genetic risk for cardiovascular disease in patients with rheumatoid arthritis: present and promises. |
| PubMedID- 23584985 | Novel risk factors for cardiovascular disease in rheumatoid arthritis. |
| PubMedID- 24458537 | The effect of disease duration and disease activity on the risk of cardiovascular disease in rheumatoid arthritis patients. |
| PubMedID- 21608334 | Effects of adalimumab treatment on vascular disease associated with early rheumatoid arthritis. |
| PubMedID- 25754335 | rheumatoid arthritis (ra) associates with increased cardiovascular disease (cvd) mortality thought to be due to accelerated arterial disease. |
| PubMedID- 26082375 | Pathophysiologic mechanisms and risk management of cardiovascular disease in patients with rheumatoid arthritis. |
| PubMedID- 24874661 | Bacteria in the adventitia of cardiovascular disease patients with and without rheumatoid arthritis. |
| PubMedID- 21520672 | Excess mortality from cardiovascular disease in patients with rheumatoid arthritis--nsaid a possible cause. |
| PubMedID- 23256829 | The risk of cardiovascular disease associated with rheumatoid arthritis equals that of diabetes mellitus. |
| PubMedID- 23666917 | Objective: rheumatoid arthritis (ra) is associated with cardiovascular disease (cvd), but little is known about its association with another form of vascular disorder, venous thromboembolism (vte). |
| PubMedID- 24268008 | Cardiovascular disease in rheumatoid arthritis. |
| PubMedID- 26180748 | The association of rheumatoid arthritis (ra) with increased vascular disease is well established (kitas et al. |
| PubMedID- 22284683 | We also suggest strategies for risk stratification and treatment of cardiovascular disease in patients with rheumatoid arthritis. |
| PubMedID- 21345288 | Lack of association between retn rs1862513 polymorphism and cardiovascular disease in rheumatoid arthritis patients. |
| PubMedID- 21109513 | Cardiovascular disease in rheumatoid arthritis: state of the art and future perspectives. |
| PubMedID- 21071477 | Tumour necrosis factor antagonists and the risk of cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review. |
| PubMedID- 24498229 | Conclusion: in observational studies the finding of incident cardiovascular disease in patients with rheumatoid arthritis exposed to glucocorticoids is strongly confounded by indication due to high disease activity. |
Page: 1 2